Convintro herbicide will target tough-to-control weeds such as water hemp and palmer amaranth. In this episode of Managing for Profit, Jody Gander, the technical manager for crop protection at Bayer ...

Legislators who favor the liability protection for Bayer say lawsuits alleging the herbicide Roundup causes cancer would hurt the agriculture industry facing increased costs. Opponents demand ...

Shares of BridgeBio Pharma (NASDAQ:BBIO), currently valued at $5.88 billion, witnessed an uptick as Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target to $49 from $48 while ...

EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under the Beyonttra brand name for treating ATTR-CM.

Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 37.33 ...

Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in ...